Institutions / Cormorant Asset Management, LP / Holdings
Back to Cormorant Asset Management, LP

Cormorant Asset Management, LP

All holdings · as of Dec 31, 2025

32 positions

CompanyClassValue ↓Shares% of portfolio
Praxis Precision Medicines, Inc.—$280.00M950,00015.9%
BridgeBio Oncology Therapeutics, Inc.BBOTCommon Stock$223.84M17,878,59412.7%
ABIVAX SA—$182.05M1,350,00010.3%
EyePoint, Inc.—$151.00M8,265,0008.6%
Rapport Therapeutics, Inc.RAPPCommon Stock$91.85M3,027,5215.2%
BridgeBio Pharma, Inc.—$91.79M1,200,0005.2%
BRIGHT MINDS BIOSCIENCES INC.—$82.67M1,059,3314.7%
Edgewise Therapeutics, Inc.—$81.52M3,285,0004.6%
Olema Pharmaceuticals, Inc.—$68.75M2,750,0003.9%
MoonLake ImmunotherapeuticsMLTXCommon Stock$57.40M4,355,4333.3%
INSMED INC—$47.86M275,0002.7%
enGene Therapeutics Inc.—$36.12M4,000,0002.0%
ALUMIS INC.ALMSCommon Stock$35.48M3,635,5962.0%
MBX Biosciences, Inc.MBXCommon Stock$35.32M1,120,0002.0%
NEWAMSTERDAM PHARMA COMPANY—$35.08M1,000,0002.0%
CENTESSA PHARMACEUTICALS PLC—$33.14M1,325,0001.9%
Pharvaris N.V.—$30.05M1,083,0001.7%
BioAge Labs, Inc.BIOACommon Stock$27.00M2,040,6051.5%
ASCENDIS PHARMA A/S—$21.32M100,0001.2%
TARSUS PHARMACEUTICALS, INC.—$20.47M250,0001.2%
Corbus Pharmaceuticals Holdings, Inc.CRBPCommon Stock$19.09M2,344,9711.1%
GH RESEARCH PLC—$16.51M1,300,0000.9%
Oruka Therapeutics, Inc.—$16.17M533,3400.9%
Arcutis Biotherapeutics, Inc.—$14.52M500,0000.8%
Crinetics Pharmaceuticals, Inc.—$13.96M300,0000.8%
Axsome Therapeutics, Inc.—$13.70M75,0000.8%
Cabaletta Bio, Inc.—$9.64M4,400,0000.5%
Janux Therapeutics, Inc.—$8.97M650,0000.5%
Cogent Biosciences, Inc.—$7.99M225,0000.5%
VAXCYTE, INC.—$5.77M125,0000.3%
Amylyx Pharmaceuticals, Inc.—$4.83M400,0000.3%
Biohaven Ltd.—$112.9K10,0000.0%
← PrevPage 1 of 1Next →